Immuron (IMRN) Other Non-Current Assets (2018 - 2023)
Immuron (IMRN) posted quarterly Other Non-Current Assets of $7846.9 for Q4 2023, down 21.15% year-over-year from $9951.3 in Q4 2022, and down 99.35% quarter-over-quarter from $1.2 million in Q3 2023.
Immuron (IMRN) Other Non-Current Assets (2018 - 2023) Analysis & Trends
Immuron's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $7846.9 for Q4 2023.
- In Q4 2023, Other Non-Current Assets fell 21.15% year-over-year to $7846.9; the TTM figure through Dec 2023 stood at $7846.9 (down 21.15% YoY), while the FY2023 annual figure was $18340.3, up 84.3% from the prior year.
- Other Non-Current Assets for Q4 2023 stood at $7846.9, down from $1.2 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $17.8 million in Q2 2022, with the low at $7846.9 in Q4 2023.
- The 4-year median for Other Non-Current Assets is $573601.7 (2023), against an average of $2.7 million.
- The sharpest annual moves came in 2020 and 2023: Other Non-Current Assets fell 13.45% in 2020, then slumped 99.93% in 2023.
- Immuron's Other Non-Current Assets stood at $1.3 million in 2019, then declined by 13.45% to $1.1 million in 2020, then plunged by 99.12% to $9951.3 in 2022, then retreated by 21.15% to $7846.9 in 2023.
- Business Quant data shows IMRN's Other Non-Current Assets at $7846.9 in Q4 2023, $1.2 million in Q3 2023, and $18340.3 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - | 100,926.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 7,846.88 |
| Sep 28, 2023 | 1.20 Mn |
| Aug 30, 2023 | 18,340.34 |
| Jun 30, 2023 | 12,257.96 |
| Dec 31, 2022 | 9,951.34 |
| Jun 30, 2022 | 17.81 Mn |
| Jun 30, 2020 | 1.13 Mn |
| Jun 30, 2019 | 1.30 Mn |
| Jun 30, 2018 | 1.64 Mn |